BridgeMD
New treatment option for Distal Radius Fracture
Official title Home-Based Photobiomodulation Effects in the Postoperative Period of Distal Radius Fractures
ClinicalTrials.gov ID: NCT07426926
What this study is testing
- What it's testing
- This double-blind, randomized controlled clinical trial aims to evaluate the adjuvant effect of home-based photobiomodulation (PBM) therapy on the rehabilitation of surgically treated DRFs combined with an unsupervised home exercise program. A total of 42 participants will be randomly allocated into two groups.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Adults aged 18 to 65 years,
- Both sexes,
- Patients with isolated, closed distal radius fractures with displacement and surgical indication,
- Surgical indication defined by instability criteria:
- Dorsal tilt of the distal fragment \>20°,
You likely can't join if
- Previous wrist injuries, sequelae, or motor deficits due to neurological lesions,
- Pathological fractures,
- Ipsilateral fractures in other regions of the limb,
- Neurovascular injury with sensory deficit at the fracture site,
- Local or systemic contraindications to surgery or postoperative recovery,
- History of photosensitivity,
See the full eligibility criteria
- Adults aged 18 to 65 years,
- Both sexes,
- Patients with isolated, closed distal radius fractures with displacement and surgical indication,
- Surgical indication defined by instability criteria:
- Dorsal tilt of the distal fragment \>20°,
- Radial shortening ≥10 mm,
- Articular incongruity,
- Dorsal comminution,
- Fractures classified as Fernandez types I, II, or III,
- Fractures classified as AO/OTA types 2R3A2, 2R3A3, 2R3B, or 2R3C (except 2R3C3).
- Previous wrist injuries, sequelae, or motor deficits due to neurological lesions,
- Pathological fractures,
- Ipsilateral fractures in other regions of the limb,
- Neurovascular injury with sensory deficit at the fracture site,
- Local or systemic contraindications to surgery or postoperative recovery,
- History of photosensitivity,
- Neurological and/or psychiatric disorders,
- Proliferative or infectious skin lesions at the wrist region,
- Pregnancy,
- Surgical complications (neurological or vascular injuries, or fracture line extension) - excluded from analysis but reported.
The study team makes the final eligibility decision.
Where it's taking place
- São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.